CAR T Archives -

Why cell therapy manufacture is a team sport

https://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/

Welcome to the CAR-TCR Summit Europe 2021

https://pharmaphorum.com/events/welcome-to-the-car-tcr-summit-europe-2021/

Cellular Immunotherapies for Solid Tumors Summit

https://pharmaphorum.com/events/cellular-immunotherapies-for-solid-tumors-summit/

CAR-T Beyond Oncology Digital Summit

https://pharmaphorum.com/events/car-t-beyond-oncology-digital-summit/

FDA’s review date for BMS’ ide-cel sneaks under the CVR wire

https://pharmaphorum.com/news/fdas-review-date-for-bms-ide-cel-sneaks-under-the-cvr-wire/

Preparing for an influx of cell and gene therapy approvals

https://pharmaphorum.com/views-analysis-sales-marketing/preparing-influx-cell-gene-therapy-approvals/

BMS ‘bet’ with Celgene shareholders in balance after CAR-T refile

https://pharmaphorum.com/news/bms-2/

Gilead’s Kite gains some height after second CAR-T approval in US

https://pharmaphorum.com/news/gileads-kite-gains-some-height-after-second-car-t-approval-in-us/

Poseida Therapeutics aims for $115m stock market launch to fund CAR-T R&D

https://pharmaphorum.com/news/poseida-therapeutics/

Search